Skip to content
Greenway Therapeutix

Greenway Therapeutix

Paving the way for the future of natural cannabinoid therapeutics

  • About
    • Our Mission
    • Our Team
  • Canno Cream™
  • Science
    • CBD Science
    • Nanotechnology
  • News
  • Investors
  • Contact

Patients with eczema open to OTC cannabinoid products

Posted on April 19, 2022April 19, 2022 by Jeff Freeman
Posted in General

Post navigation

Greenway Therapeutix CEO, Dr. Milane, recently featured in the Dermatology Digest

Recent Posts

  • Patients with eczema open to OTC cannabinoid products
  • Greenway Therapeutix CEO, Dr. Milane, recently featured in the Dermatology Digest
  • The therapeutic potential and current landscape of cannabinoids in dermatology
  • Are CBD skincare products effective?
  • Greenway Therapeutix® is Exhibiting at the Generational Dermatology Meeting

Recent Comments

    Archives

    • April 2022
    • January 2022
    • May 2020
    • April 2020
    • October 2019
    • May 2018
    • February 2018
    • January 2018
    • December 2017

    Categories

    • General

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Greenway Therapeutics Greenway Therapeutix

    About Greenway Therapeutix®

    Greenway Therapeutix® is a medically focused Biotech Company created by Medical Doctors & Scientists. We are dedicated to the research and development of medical grade cannabinoid therapeutic products, while utilizing cutting edge nanotechnology in our delivery.

    Sitemap

    • About
      • Our Mission
      • Our Team
    • Canno Cream™
    • Science
      • CBD Science
      • Nanotechnology
    • News
    • Investors
    • Contact

    Where to Reach Us

    E-mail: info@greenwaytherapeutix.com

    Phone: (310) 494-6901

    © Copyright Greenway Therapeutix®, 2024